CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
-8.36%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$1.73B
AUM Growth
+$1.73B
(+6.9%)
Cap. Flow
+$249M
Cap. Flow
% of AUM
14.37%
Top 10 Holdings %
Top 10 Hldgs %
58.6%
Holding
44
New
9
Increased
8
Reduced
6
Closed
8
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$114M |
| 2 |
Myriad Genetics
MYGN
|
$67.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$55.3M |
| 4 |
Biogen
BIIB
|
$49.6M |
| 5 |
Abbott
ABT
|
$38.4M |
Top Sells
| 1 |
MDCO
Medicines Co
MDCO
|
$75.5M |
| 2 |
Community Health Systems
CYH
|
$57.7M |
| 3 |
Tenet Healthcare
THC
|
$56.7M |
| 4 |
Bausch Health
BHC
|
$31.2M |
| 5 |
PTC Therapeutics
PTCT
|
$28M |
Sector Composition
| 1 | Healthcare | 82.92% |
| 2 | Industrials | 1.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Teva Pharmaceuticals
TEVA
$21.1B
| $171M | 8.92% | 4,724,450 +724,450 | +18% | +$26.3M |
|
2
Viatris
VTRS
$12.3B
| $158M | 8.24% | 4,145,889 +272,889 | +7% | +$10.4M |
|
|
AGN
3
DELISTED
Allergan plc
AGN
| $114M | 5.94% | +543,000 | New | +$114M |
|
4
Gilead Sciences
GILD
$140B
| $107M | 5.59% | 1,500,000 +300,000 | +25% | +$21.5M |
|
5
Perrigo
PRGO
$3.27B
| $101M | 5.24% | 1,208,200 -5,400 | -0.4% | -$449K |
|
6
Select Medical
SEM
$1.61B
| $79.8M | 4.16% | 6,025,000 | – | – |
|
7
Nektar Therapeutics
NKTR
$568M
| $73.6M | 3.83% | 6,000,000 +2,800,000 | +88% | +$34.4M |
|
|
GHDX
8
DELISTED
Genomic Health, Inc.
GHDX
| $72.2M | 3.76% | 2,458,100 | – | – |
|
9
Brookdale Senior Living
BKD
$1.83B
| $68.3M | 3.56% | 5,500,000 +1,500,000 | +38% | +$18.6M |
|
|
10
Myriad Genetics
MYGN
$593M
| $67.7M | 3.52% | +4,060,000 | New | +$67.7M |
|
|
ENDP
11
DELISTED
Endo International plc
ENDP
| $64.3M | 3.35% | 3,902,000 -338,000 | -8% | -$5.57M |
|
|
CSII
12
DELISTED
Cardiovascular Systems, Inc.
CSII
| $60.5M | 3.15% | 2,500,000 -500,000 | -17% | -$12.1M |
|
13
Alkermes
ALKS
$4.78B
| $55.6M | 2.89% | 1,000,000 +62,700 | +7% | +$3.48M |
|
|
14
Vertex Pharmaceuticals
VRTX
$100B
| $55.3M | 2.88% | +750,000 | New | +$55.3M |
|
15
Orthofix Medical
OFIX
$592M
| $54.3M | 2.83% | 1,500,000 | – | – |
|
16
LivaNova
LIVN
$3.08B
| $54M | 2.81% | 1,200,000 +200,000 | +20% | +$8.99M |
|
|
17
Biogen
BIIB
$19.4B
| $49.6M | 2.58% | +175,000 | New | +$49.6M |
|
|
UAM
18
DELISTED
Universal American Corp
UAM
| $48.5M | 2.53% | 4,875,000 -1,000,000 | -17% | -$9.95M |
|
|
19
Abbott
ABT
$231B
| $38.4M | 2% | +1,000,000 | New | +$38.4M |
|
20
CONMED
CNMD
$1.68B
| $33.1M | 1.73% | 750,000 | – | – |
|
|
ATHN
21
DELISTED
Athenahealth, Inc.
ATHN
| $31.6M | 1.64% | +300,000 | New | +$31.6M |
|
|
AMAG
22
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $21.3M | 1.11% | 611,390 | – | – |
|
|
ELGX
23
DELISTED
Endologix Inc
ELGX
| $20.8M | 1.08% | 3,635,000 +2,635,000 | +264% | +$15.1M |
|
|
ELOS
24
DELISTED
Syneron Medical Ltd
ELOS
| $19.7M | 1.03% | 2,347,593 | – | – |
|
|
NVTA
25
DELISTED
Invitae Corporation
NVTA
| $19M | 0.99% | 2,398,123 -43,999 | -2% | -$349K |
|